Physicians’ perceptions of HCC conversion/downstaging therapy: a nationwide survey among tertiary hospital physicians in China

Abstract Background and objective Conversion or downstaging therapy for intermediate and advanced unresectable hepatocellular carcinoma (HCC) has emerged as a major focus of clinical practice and research in recent years. This study aims to investigate the current clinical application of conversion...

Descripció completa

Dades bibliogràfiques

Autors principals:	Xinyu Bi, Xiao Liang, Guang Tan, Hai-Tao Zhao, Tao Huang, Ming Zhao, Jinzhang Chen, Xiao-Dong Zhu, Jianfeng Xue, Hui-Chuan Sun, Jianqiang Cai, China Liver Cancer Study Group Young Investigators(CLEAP)
Format:	Artigo
Idioma:	Inglês
Publicat:	Springer 2026-05-01
Col·lecció:	Holistic Integrative Oncology
Matèries:	Hepatocellular carcinoma Conversion therapy Downstaging Survey Targeted therapy
Accés en línia:	https://doi.org/10.1007/s44178-026-00256-x
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!